Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | SVP, Entertainment | October 01, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 166,803 |
Last balance in matching sequence
After 2026-10-01 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-01 · Exercise / conversion · Acquired 7,667 · Balance 174,470 F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 2 · 2026-10-01 · Sale · Disposed 6,831 · Balance 167,639 F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 3 · 2026-10-01 · Sale · Disposed 836 · Balance 166,803 F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.50 · Expires 2026-12-15 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 7,667 · Balance 0 F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 8,680 | $65.33 | $567,028.81 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,255 F3 · price: This transaction was executed in multiple trades at prices ranging from $64.69 to $65.685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 20,700 | $33.15 | $686,205.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 29,300 | $66.30 | $1,942,692.55 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,235 F2 · price: This transaction was executed in multiple trades at prices ranging from $65.91 to $66.655. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 29,300 | $30.49 | $893,357.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 16, 2022 Filed May 17, 2022 20:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 185 | $74.63 | $13,806.55 |
DisclosureSEC source: 0001209191-22-029596 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,235 F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 248 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022. Read SEC document |
| May 12, 2022 Filed May 12, 2022 21:56 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $73.00 | $73,000.80 |
DisclosureSEC source: 0001209191-22-028613 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,172 F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 11, 2022 Filed May 12, 2022 21:56 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 500 | $72.62 | $36,307.50 |
DisclosureSEC source: 0001209191-22-028613 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,172 F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 01:38 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,240 | $92.00 | $114,080.00 |
DisclosureSEC source: 0001209191-21-070703 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,672 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 35,653 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 02:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,373 | $91.80 | $126,041.40 |
DisclosureSEC source: 0001209191-21-070098 · doc4.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,912 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 38,153 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 35,244 | $0.00 Strike: $91.80 | $0.00 |
DisclosureSEC source: 0001209191-21-070098 · doc4.xml · derivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,244 Underlying: Class A Common Stock · 35,244 shares Expires 2031-12-15 F7 · derivative.exercise_date: This option was granted for a total of 35,244 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 8,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070098 · doc4.xml · derivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 Underlying: Class A Common Stock · 8,513 shares Expires not disclosed F6 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 17,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070098 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,285 F3 · acquired: Award represents a total of 17,027 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2020. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 41,153 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,119 | $90.55 | $191,875.45 |
DisclosureSEC source: 0001209191-21-070098 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,258 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 24,126 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 02:00 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 87 | $90.23 | $7,850.01 |
DisclosureSEC source: 0001209191-21-065348 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,377 F1 · balance_after: Shares held following the reported transactions include 30,251 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.